Search for: "Takeda Pharmaceuticals" Results 201 - 220 of 451
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 May 2017, 8:00 am by Robert Kreisman
Related blog posts: $9 Billion Actos Damage Award Against Takeda and Lilly is Upheld $90 Million Settlement Paid by Pharmaceutical Company For Its Unfair and Deceptive Promotion of Diabetes Drug $124 Million Penalty to Stand Against the Drug Maker Janssen for the Drug Risperdal     [read post]
13 Nov 2012, 4:40 pm
Already, numerous plaintiffs have filed Actos injury lawsuits suing Takeda Pharmaceuticals because they believe the diabetes drug caused their bladder cancer. [read post]
17 Sep 2011, 5:43 am by Jonathan Rosenfeld
The lawsuit alleges that Actos' manufacturer, Takeda Pharmaceuticals North America (and other entities including: Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals Company Ltd., Takeda Pharmaceuticals America, Takeda San Diego Inc., Takeda Pharmaceuticals International Inc and Eli Lilly and Company), was negligent for not providing any warnings regarding the increased bladder… [read post]
16 Apr 2014, 9:05 pm by Walter Olson
” [John Stossel] Tweet Tags: Arkansas, FDA, Louisiana, Mark Lanier, medical, medical malpractice, pharmaceuticals, strippers and exotic dancersMedical roundup is a post from Overlawyered - Chronicling the high cost of our legal system [read post]
1 Jun 2012, 9:48 am
Takeda Pharmaceutical, the manufacturer of Alogliptin, received more discouraging news from the United States Food and Drug Administration (FDA). [read post]
22 Jan 2015, 12:16 pm by Dr. Shezad Malik
Takeda Pharmaceuticals America Inc., et al, case number CGC-12-518535). [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
(patent infringement) 11/6: Takeda Pharmaceutical Company Ltd. and Takeda Pharmaceuticals North America Inc. v. [read post]
23 Jul 2020, 9:15 am by Jonathan Stroud
The District Court activity was driven by new complaints in existing campaigns, some new ANDA/aBLA litigations related to pharmaceutical generic entry, a smattering of company disputes, and a new campaign by Raymond Anthony Joao. [read post]
10 Jan 2012, 12:43 pm by Phil
Mamula, Reporter for the Pittsburgh Business Times: Takeda Pharmaceutical, Watson Pharmaceuticals and Andrx Labs have sued generic drugmaker Mylan Inc. for patent infringement in connection with its plans to market pioglitazone hydrochloride and extended release metformin hydrochloride tablets, Canonsburg-based Mylan announced Monday. [read post]
4 Mar 2020, 7:11 am by Wim Vandenberghe
The Innovative Medicines Initiative (IMI) was created in 2008 as a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA).[1] Its overall goal is to increase the competitiveness of R&D in the European pharmaceutical sector by encouraging companies to work with each other and with the public sector. [read post]
23 Jul 2019, 7:38 am by Brian Cordery
This included chimeric, humanized or human antibodies and each could be made into a pharmaceutical composition comprising such antibodies. [read post]
16 Apr 2014, 11:03 am by admin
Recently, the United States Supreme Court had an opportunity to clarify this pleading standard, when it considered whether to review the Fourth Circuit’s decision to affirm the dismissal of a sales rep-relator’s qui tam action, alleging Takeda Pharmaceuticals promoted its Kapidex drug for unapproved uses. [read post]
7 May 2012, 10:51 am by Rantanen
By Jason Rantanen Otsuka Pharmaceutical Co., Ltd. v. [read post]
25 Dec 2012, 1:54 pm
Takeda Pharmaceutical Co., of which Mutual is an indirect unit, has responded by invoking federal law, which does not allow drugs with FDA approval to be the target of drug defect lawsuits. [read post]
3 Oct 2023, 9:50 am by Seeger Weiss
Plaintiffs have yet to reach a settlement with Takeda Pharmaceuticals, the maker of PPI drugs Prevacid and Dexilant, and will continue to pursue claims against the company. [read post]